United Therapeutics saw the highest growth of 1.14% in patent filings in April and 1.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.14% and grants by 1.49%. GlobalData’s DataBook provides a comprehensive analysis of United Therapeutics’s patent filings and grants. Buy the databook here.
United Therapeutics has been focused on protecting inventions in United States(US) with ten publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 21% filings and 50% grants. The United States(US), Australia(AU), Israel(IL), and Japan(JP) patent Office are among the top ten patent offices where United Therapeutics is filings its patents. Among the top granted patent authorities, United Therapeutics has 50% of its grants in United States(US).
Johnson & Johnson could be the strongest competitor for United Therapeutics
In terms of grant share, United Therapeutics stands in ninth position among its competitors. Johnson & Johnson and United Therapeutics secured the top positions according to recent patent publication data.
Patents related to 3d printing and cell & gene therapy lead United Therapeutics's portfolio
United Therapeutics has the highest number of patents in 3d printing followed by, cell & gene therapy and industrial automation. For 3d printing, nearly 43% of patents were filed and 25% of patents were granted in Q2 2024.
Petrochemicals related patents lead United Therapeutics portfolio followed by pulmonary hypertension, and paints and inks
United Therapeutics has highest number of patents in petrochemicals followed by pulmonary hypertension, paints and inks, pulmonary arterial hypertension, and printing inks. For petrochemicals, nearly 32% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of United Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.